Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV immunoglobulin with R-CHOP in elderly diffuse large B cell lymphoma
KCT0005626Phase 2Completed
- Sponsor
- GC Biopharma
- Start
- Jul 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of immune globulin in diffuse large B-cell lymphoma (DLBCL) and non-Hodgkin lymphoma (NHL), sponsored by GC Biopharma. Started Jul 2021; status: completed.
02
Drugs
immune globulin
03
Conditions
diffuse large B-cell lymphoma (DLBCL)non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on KCT0005626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005626.